A more effective system is needed to ensure ADHD patients are monitored properly after beginning medication, but without increasing the strain on clinic resources. Mobile phone technology offers the potential to meet this need. Completed project. See publication: Developing mHealth Remote Monitoring Technology for Attention Deficit Hyperactivity Disorder: A Qualitative Study Eliciting User Priorities and Needs
Attention Deficit-Hyperactivity Disorder (ADHD) is characterised by three core behaviours; inattention, hyperactivity and impulsivity. ADHD is thought to affect between 3-5% of school aged children and young people in the UK, with an increased awareness that these symptoms typically continue into adulthood. Once diagnosed, current NICE guidelines recommend practitioners maintain weekly contact with their patients, and at least at each medication dose change. Due to constraints on time and resources, monitoring of response to treatment and changes in symptoms over time currently does not meet NICE guidelines in some NHS Trusts. This also means that the time taken for patients to become stable on their optimum dose of medication can be longer than recommended.
The aim of the iRAM study was to initially run focus groups to explore the idea of using mobile phone technology to assist in the treatment and monitoring of ADHD. These focus groups gathered opinions from children and adults with ADHD, parents of children with ADHD and NHS staff to gain a greater understanding of the needs of each participant group. These focus groups ran across four counties; Nottinghamshire, Leicestershire, Derbyshire and Lincolnshire in order to gain a better understanding of local differences in care. Results were analysed qualitatively and increased understanding of user requirements to feed into the development and testing of new smartphone applications for ADHD support, published in JMIR.